Q2 2021 13F Holders as of 6/30/2021
-
Type / Class
-
Equity / Class A Common Stock, par value $0.01
-
Shares outstanding
-
316M
-
Number of holders
-
153
-
Total 13F shares, excl. options
-
99.5M
-
Shares change
-
-1.74M
-
Total reported value, excl. options
-
$510M
-
Value change
-
-$13.6M
-
Put/Call ratio
-
1.18
-
Number of buys
-
75
-
Number of sells
-
-72
-
Price
-
$5.12
Significant Holders of Amneal Pharmaceuticals, Inc. - Class A Common Stock, par value $0.01 (AMRX) as of Q2 2021
183 filings reported holding AMRX - Amneal Pharmaceuticals, Inc. - Class A Common Stock, par value $0.01 as of Q2 2021.
Amneal Pharmaceuticals, Inc. - Class A Common Stock, par value $0.01 (AMRX) has 153 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 99.5M shares
of 316M outstanding shares and own 31.5% of the company stock.
Largest 10 shareholders include Fosun International Ltd (21.5M shares), TPG Group Holdings (SBS) Advisors, Inc. (16.2M shares), VANGUARD GROUP INC (11.5M shares), BlackRock Inc. (7.09M shares), Eversept Partners, LP (5.62M shares), Neuberger Berman Group LLC (3.37M shares), STATE STREET CORP (2.74M shares), Nuveen Asset Management, LLC (2.22M shares), JACOBS LEVY EQUITY MANAGEMENT, INC (2.1M shares), and VICTORY CAPITAL MANAGEMENT INC (1.92M shares).
This table shows the top 153 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.